New York, NY —With Google, Apple and a slew of other tech companies looking to participate in the health space, Verizon is jumping aboard with their new telemedicine platform “Verizon Virtual Visits”.

According to Rich Black, vice president of Verizon’s healthcare practice: “We are seeing a shift in how care is delivered in the U.S. With Verizon Virtual Visits, patients and providers alike can benefit from the use of technology to provide medical care via an enterprise-class technology solution developed with the security, performance and reliability essential to healthcare delivery.”

Using a smartphone app, patients can securely connect to an HCP after answering a brief set of questions that help guide the conversation. The physician can provide an appropriate course of treatment as well as electronically send a prescription all while remaining HIPAA compliant using their own data platform called “Verizon’s HIPAA-enabled Cloud.”

In an effort to identify societal behaviors and respond using their already established mobile assets, Verizon’s vision is to empower its users through patient engagement and improved healthcare solutions through technology. “We believe our latest mobile health offering can go a long way to enable a more efficient and effective U.S. healthcare system,” said Black.

 

Posted By: Mike Martins

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.